Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS)
1 clinical trials · Condition
◉ Watch Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS)
| Record | Firm | Date |
|---|---|---|
| Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation (NCT06465953) | Institut de Recherches Internationales Servier | 2024-12-03 |
Track Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) automatically
Every clearance here is in the API, with alerts when new ones post.